Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
Xiang Cai
Huanyi Cao
Meijun Wang
Piaojian Yu
Xiaoqi Liang
Hua Liang
Fen Xu
Mengyin Cai
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s00018-025-05688-8
Apr 16, 2025
Version published to 10.21203/rs.3.rs-5563608/v1 on Research Square
Apr 2, 2025
Related articles
SGLT2 Inhibition Ameliorates Age-Dependent Renovascular Rarefaction
This article has 13 authors:
Anastasia Paulmann
Matthew D. Cox
Tom Boewer
Hannah M. Somers
Heath Fuqua
Ryan P. Seaman
Joel H. Graber
Anchal Mahajan
Cory P. Johnson
Laura L. Beverly-Staggs
Sonia Sandhi
Heiko Schenk
Hermann Haller
The impact of dapagliflozin for the myocardial metabolomic profiles of mice with chronic heart failure induced by a high fat diet
This article has 4 authors:
Feng Hu
Jinhua Huang
Qiong Jiang
Wenkun Liu
Endothelial Kallikrein-Related Peptidase 8 Promotes Diabetic Nephropathy through a LIFR dependent mechanism
This article has 9 authors:
Jiankui Du
Mingyang Li
Ying Jiang
Zhengshan Tang
Danhong Xu
Hongling Yin
Jihong Yuan
Xiaoyan Zhu
Xin Ni
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up